针对PET/CT偶然发现乳腺病灶提出诊断算法的初步研究:将BI-RADS词典用于超声并结合SUVmax
本研究纳入51例患者的56个PET/CT偶然发现乳腺病灶,均在PET检查后1个月内接受乳腺超声检查,最终经组织学诊断或2年随访验证。基于SUVmax截断值2和3.7,结合BI-RADS≥4为高度可疑恶性,构建诊断算法:BI-RADS<4且SUVmax≥3.7者需活检,BI-RADS<4且SUVmax在2~3.7之间者可短期随访,BI-RADS<4且SUVmax<2者可常规筛查。
要点
- BI-RADS≥4与SUVmax≥2诊断敏感度均为80.0%,但BI-RADS≥4特异度92.7%高于SUVmax≥2的73.9%。
- SUVmax≥3.7联合BI-RADS诊断敏感度90.0%、特异度91.3%、准确率91.1%。
- BI-RADS<4且SUVmax≥3.7者应进行活检,BI-RADS<4且SUVmax<2者可常规筛查。
核心结论
- PET/CT偶然发现乳腺病灶中,BI-RADS<4但SUVmax≥3.7者需活检;BI-RADS高且SUVmax低者可保留活检。
研究设计与样本
- 单中心初步研究,纳入51例患者的56个PET/CT偶然发现乳腺病灶,均在PET检查后1个月内行乳腺超声,最终经组织学诊断或2年随访验证。
诊断标准与关键数值
- BI-RADS≥4视为高度可疑恶性。
- SUVmax截断值2和3.7分别基于敏感度>60.0%时最大特异度和特异度>60.0%时最大敏感度计算。
- SUVmax≥2、SUVmax≥3.7、BI-RADS≥4的敏感度分别为80.0%、60.0%、80.0%,特异度分别为73.9%、95.7%、92.7%,准确率分别为75.0%、89.3%、90.2%。
- SUVmax≥2联合BI-RADS的敏感度100.0%、特异度69.6%、准确率75.0%;SUVmax≥3.7联合BI-RADS的敏感度90.0%、特异度91.3%、准确率91.1%。
临床应用与阅片要点
- 对PET/CT偶然发现的乳腺病灶,可结合BI-RADS分级与SUVmax值评估恶性风险。
- BI-RADS<4且SUVmax≥3.7的病灶需活检。
- BI-RADS<4且SUVmax在2~3.7之间的病灶可短期随访。
- BI-RADS<4且SUVmax<2的病灶可常规筛查。
- BI-RADS高且SUVmax低的患者可保留活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a diagnostic algorithm for positron emission tomography (PET)-detected incidental breast lesions using both breast imaging reporting and data system (BI-RADS) and maximum standardized uptake value (SUVmax) criteria.
METHODS: Fifty-six PET-detected incidental breast lesions from 51 patients, which were subsequently investigated by breast ultrasound within 1 month of the PET study, constituted the study cohort and they were finally verified by tissue diagnosis or a 2-year follow-up. Based on the maximum specificity with sensitivity > 60.0% and maximum sensitivity with specificity > 60.0%, two SUVmax cutoff values were calculated at 2 and 3.7. BI-RADS ≥ 4 was considered as highly suspicious for malignancy. The diagnostic accuracies were estimated for SUVmax levels above or below the cutoff points combined with the BI-RADS suspicion level.
RESULTS: Overall, 46 benign and 10 malignant lesions were studied. The diagnostic characteristics of SUVmax ≥ 2, SUVmax ≥ 3.7, and BI-RADS ≥ 4 were 80.0%, 60.0%, and 80.0% for sensitivity, 73.9%, 95.7%, and 92.7% for specificity, and 75.0%, 89.3%, and 90.2% for accuracy, respectively. When the SUVmax threshold was set at 2, combined with BI-RADS suspicion level, the sensitivity, specificity, and accuracy were 100.0%, 69.6%, and 75.0%, respectively. The results for SUVmax threshold set at 3.7 combined with BI-RADS were 90.0%, 91.3%, and 91.1% for the sensitivity, specificity, and accuracy, respectively. A diagnostic algorithm was accordingly generated.
CONCLUSION: The need for biopsy should be justified in low BI-RADS lesions presenting with high SUVmax at 3.7 or higher. The biopsy of patients with high B-IRADS and low SUVmax could be preserved.
KEY POINTS: • A diagnostic algorithm was developed for PET-detected incidental breast lesions using both BI-RADS and SUVmax criteria. • Diagnostic performance was calculated separately and conjunctively for SUVmax ≥ 2, SUVmax ≥ 3.7, and BI-RADS ≥ 4. • The need for biopsy can be justified in BI-RADS < 4 lesions with SUVmax ≥ 3.7. Lesions with BI-RADS < 4 and indeterminate SUVmax (2 < SUVmax < 3.7) benefit from a short-interval follow-up. BI-RADS < 4 lesions with SUVmax < 2 may confidently be scheduled for routine screening.
引用
- Bakhshayeshkaram M, Salehi Y, Abbasi M, et al. A preliminary study to propose a diagnostic algorithm for PET/CT-detected incidental breast lesions: application of BI-RADS lexicon for US in combination with SUVmax. Eur Radiol. 2019. PMID: 30887201. doi:10.1007/s00330-019-06106-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。